Preventive Medicine Doctors in Akron, OH Accepting Medicare

8 Preventive Medicine doctors found. Showing 1 - 8

Dr. Richard Neil O'desky, DO Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 2554 Ira Rd, Akron, OH 44333 Phone: 330-666-5832

Seth Michael Sigler, DO Medicare: Medicare Enrolled Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-6119    Fax: 330-375-7813

Richard L. Vincent, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 676 S Broadway St, Suite 200, Akron, OH 44311 Phone: 615-778-4066    Fax: 615-778-9114

Marguerite Ann Erme, D.O. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1867 W Market St, Akron, OH 44313 Phone: 330-812-3865    Fax: 330-923-7558

Dr. Stephen Gregory Kaiser, D.O. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, Summa Center For Corporate Health, Akron, OH 44310 Phone: 330-379-5959    Fax: 330-379-5902

Anh Tu Tran, M.D., M.P.H. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Innovation Way, Akron, OH 44316 Phone: 330-796-6344

Ray E Benson Iii, D.O. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Firestone Pkwy, Akron, OH 44301 Phone: 330-724-3345

Dr. James Michael Moser, M.D., M.P.H. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 697 Woodledge Dr, Akron, OH 44313 Phone: 330-836-9246

News Archive

BELLUS Health, Celtic Therapeutics initiate KIACTA global confirmatory phase III clinical study for AA amyloidosis

BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.

DNA Heritage overcomes patent claims

DNA Heritage has recently overcome patent claims held by a competitor which would have severely restricted the use of DNA testing and databases that allow families around the world to match and connect up through their DNA.

Aetna announced participation in New York State's managed long-term care program

Aetna Better Health of New York today announced its participation in New York State's managed long-term care (MLTC) program. Aetna Better Health of New York, an Aetna Medicaid company, will serve people eligible for the state program in three New York City boroughs—Manhattan, Brooklyn and Queens—as well as Nassau and Suffolk counties on Long Island.

Relieve stress: Exercise, meditate, delegate tasks, diet and be happy

It's impossible to know, unless you're Urban Meyer or one of his doctors, what exactly caused the two-time college football championship winner to see-saw decisions about his prestigious professional career and his family life.

Two-color stimulated emission depletion microscopy in living cells

Researchers are able to achieve extremely high-resolution microscopy through a process known as stimulated emission depletion (STED) microscopy. This cutting-edge imaging system has pushed the performance of microscopes significantly past the classical limit, enabling them to image features that are even smaller than the wavelength of light used to study them.

Read more Medical News

› Verified 8 days ago